Patent Assignment
Reel/Frame 067118/0062
Assignment of Assignor's Interest
Recorded: 2024-04-16
Pages: 4
Assignee
SAVIENT PHARMACEUTICALS, INC.
ONE TOWER CENTER BOULEVARD, EAST BRUNSWICK, NEW JERSEY, 08816
Covered Property
(1)
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 16, 2024
From: SAVIENT PHARMACEUTICALS, INC.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 067125/0144 →
Change of Name
Apr 16, 2024
From: CREALTA PHARMACEUTICALS LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 067125/0168 →
Assignment of Assignor's Interest
Apr 16, 2024
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 067125/0650 →